Hemogenyx Pharmaceuticals PLC Announces...Grant of Share Awards (ACCESS Newswire) - Oct 29, 2025 - "As a reward for the Hemogenyx team's outstanding contribution to the HG-CT-1 program and their dedication to advancing this groundbreaking therapy, the Company has granted a total of 6,000 Restricted Share Units ('RSUs') to key team members under its existing equity incentive arrangements."
Commercial • Acute Myelogenous Leukemia
|